Cellectar Biosciences, Inc. (CLRB)
2.355
-0.16
(-6.18%)
USD |
NASDAQ |
Jun 09, 16:00
2.375
+0.02
(+0.85%)
After-Hours: 19:12
Cellectar Biosciences EPS Diluted (Quarterly) : -1.333 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Karyopharm Therapeutics, Inc. | -1.236 |
| Forum Markets, Inc. | -3.580 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.654M |
| Total Expenses (Quarterly) | 5.654M |
| Enterprise Value | 5.727M |
| Earnings Yield | -313.1% |
| Normalized Earnings Yield | -327.78 |